Alleviation of hippocampal necroptosis and neuroinflammation by NecroX-7 treatment after acute seizures

Temporal lobe epilepsy (TLE) is one of the most common neurological disorders, but still one-third of patients cannot be properly treated by current medication. Thus, we investigated the therapeutic effects of a novel small molecule, NecroX-7, in TLE using both a low [Mg2+]o-induced epileptiform act...

Full description

Bibliographic Details
Main Authors: Yihyun Roh, Su Bin Lee, Minseo Kim, Mi-Hye Kim, Hee Jung Kim, Kyung-Ok Cho
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1187819/full
_version_ 1797756409845121024
author Yihyun Roh
Su Bin Lee
Minseo Kim
Mi-Hye Kim
Hee Jung Kim
Kyung-Ok Cho
Kyung-Ok Cho
author_facet Yihyun Roh
Su Bin Lee
Minseo Kim
Mi-Hye Kim
Hee Jung Kim
Kyung-Ok Cho
Kyung-Ok Cho
author_sort Yihyun Roh
collection DOAJ
description Temporal lobe epilepsy (TLE) is one of the most common neurological disorders, but still one-third of patients cannot be properly treated by current medication. Thus, we investigated the therapeutic effects of a novel small molecule, NecroX-7, in TLE using both a low [Mg2+]o-induced epileptiform activity model and a mouse model of pilocarpine-induced status epilepticus (SE). NecroX-7 post-treatment enhanced the viability of primary hippocampal neurons exposed to low [Mg2+]o compared to controls in an MTT assay. Application of NecroX-7 after pilocarpine-induced SE also reduced the number of degenerating neurons labelled with Fluoro-Jade B. Immunocytochemistry and immunohistochemistry showed that NecroX-7 post-treatment significantly alleviated ionized calcium-binding adaptor molecule 1 (Iba1) intensity and immunoreactive area, while the attenuation of reactive astrocytosis by glial fibrillary acidic protein (GFAP) staining was observed in cultured hippocampal neurons. However, NecroX-7-mediated morphologic changes of astrocytes were seen in both in vitro and in vivo models of TLE. Finally, western blot analysis demonstrated that NecroX-7 post-treatment after acute seizures could decrease the expression of mixed lineage kinase domain-like pseudokinase (MLKL) and phosphorylated MLKL (p-MLKL), markers for necroptosis. Taken all together, NecroX-7 has potential as a novel medication for TLE with its neuroprotective, anti-inflammatory, and anti-necroptotic effects.
first_indexed 2024-03-12T18:01:00Z
format Article
id doaj.art-fe1ce44c95ec4268a1ab824b7bd063c2
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-12T18:01:00Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-fe1ce44c95ec4268a1ab824b7bd063c22023-08-02T12:28:23ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-08-011410.3389/fphar.2023.11878191187819Alleviation of hippocampal necroptosis and neuroinflammation by NecroX-7 treatment after acute seizuresYihyun Roh0Su Bin Lee1Minseo Kim2Mi-Hye Kim3Hee Jung Kim4Kyung-Ok Cho5Kyung-Ok Cho6College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaDepartment of Medical Laser, Graduate School, Dankook University, Cheonan, Republic of KoreaCollege of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaDepartment of Medical Laser, Graduate School, Dankook University, Cheonan, Republic of KoreaDepartment of Physiology, College of Medicine, Center for Human Risk Assessment, Dankook University, Cheonan, Republic of KoreaDepartment of Pharmacology, Catholic Neuroscience Institute, Institute for Aging and Metabolic Diseases, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaDepartment of Biomedicine and Health Sciences, The Catholic University of Korea, Seoul, Republic of KoreaTemporal lobe epilepsy (TLE) is one of the most common neurological disorders, but still one-third of patients cannot be properly treated by current medication. Thus, we investigated the therapeutic effects of a novel small molecule, NecroX-7, in TLE using both a low [Mg2+]o-induced epileptiform activity model and a mouse model of pilocarpine-induced status epilepticus (SE). NecroX-7 post-treatment enhanced the viability of primary hippocampal neurons exposed to low [Mg2+]o compared to controls in an MTT assay. Application of NecroX-7 after pilocarpine-induced SE also reduced the number of degenerating neurons labelled with Fluoro-Jade B. Immunocytochemistry and immunohistochemistry showed that NecroX-7 post-treatment significantly alleviated ionized calcium-binding adaptor molecule 1 (Iba1) intensity and immunoreactive area, while the attenuation of reactive astrocytosis by glial fibrillary acidic protein (GFAP) staining was observed in cultured hippocampal neurons. However, NecroX-7-mediated morphologic changes of astrocytes were seen in both in vitro and in vivo models of TLE. Finally, western blot analysis demonstrated that NecroX-7 post-treatment after acute seizures could decrease the expression of mixed lineage kinase domain-like pseudokinase (MLKL) and phosphorylated MLKL (p-MLKL), markers for necroptosis. Taken all together, NecroX-7 has potential as a novel medication for TLE with its neuroprotective, anti-inflammatory, and anti-necroptotic effects.https://www.frontiersin.org/articles/10.3389/fphar.2023.1187819/fullNecroX-7neuroinflammationneuroprotectionnecroptosisexcitotoxicityseizure
spellingShingle Yihyun Roh
Su Bin Lee
Minseo Kim
Mi-Hye Kim
Hee Jung Kim
Kyung-Ok Cho
Kyung-Ok Cho
Alleviation of hippocampal necroptosis and neuroinflammation by NecroX-7 treatment after acute seizures
Frontiers in Pharmacology
NecroX-7
neuroinflammation
neuroprotection
necroptosis
excitotoxicity
seizure
title Alleviation of hippocampal necroptosis and neuroinflammation by NecroX-7 treatment after acute seizures
title_full Alleviation of hippocampal necroptosis and neuroinflammation by NecroX-7 treatment after acute seizures
title_fullStr Alleviation of hippocampal necroptosis and neuroinflammation by NecroX-7 treatment after acute seizures
title_full_unstemmed Alleviation of hippocampal necroptosis and neuroinflammation by NecroX-7 treatment after acute seizures
title_short Alleviation of hippocampal necroptosis and neuroinflammation by NecroX-7 treatment after acute seizures
title_sort alleviation of hippocampal necroptosis and neuroinflammation by necrox 7 treatment after acute seizures
topic NecroX-7
neuroinflammation
neuroprotection
necroptosis
excitotoxicity
seizure
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1187819/full
work_keys_str_mv AT yihyunroh alleviationofhippocampalnecroptosisandneuroinflammationbynecrox7treatmentafteracuteseizures
AT subinlee alleviationofhippocampalnecroptosisandneuroinflammationbynecrox7treatmentafteracuteseizures
AT minseokim alleviationofhippocampalnecroptosisandneuroinflammationbynecrox7treatmentafteracuteseizures
AT mihyekim alleviationofhippocampalnecroptosisandneuroinflammationbynecrox7treatmentafteracuteseizures
AT heejungkim alleviationofhippocampalnecroptosisandneuroinflammationbynecrox7treatmentafteracuteseizures
AT kyungokcho alleviationofhippocampalnecroptosisandneuroinflammationbynecrox7treatmentafteracuteseizures
AT kyungokcho alleviationofhippocampalnecroptosisandneuroinflammationbynecrox7treatmentafteracuteseizures